KIN2.DEKIN2.DEXETRA
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+64.4%
5Y CAGR+9.3%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+64.4%/yr
vs +0.0%/yr prior
5Y CAGR
+9.3%/yr
Recent acceleration
Acceleration
+64.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$4.26B+63.9%
2024$2.60B+47.4%
2023$1.76B+84.0%
2022$958.90M+12.6%
2021$851.60M-68.8%
2020$2.73B+54.1%
2019$1.77B+85.0%
2018$957.70M-27.7%
2017$1.32B+47.9%
2016$895.90M-